作者
Gemma M Dias, Caterina F Ramogida, Julie Rousseau, Nicholas A Zacchia, Cornelia Hoehr, Paul Schaffer, Kuo-Shyan Lin, François Bénard
发表日期
2018/3/1
期刊
Nuclear medicine and biology
卷号
58
页码范围
1-7
出版商
Elsevier
简介
Introduction
Zirconium-89 (89Zr, t1/2 = 78.4 h) liquid target (LT) production offers an approach to introduce this positron-emitting isotope to cyclotron centres without the need for a separate solid target (ST) production set up. We compared the production, purification, and antibody radiolabeling yields of 89Zr-(LT) and 89Zr-(ST), and assessed the feasibility of 89Zr-(LT) for preclinical PET/CT.
Methods
89Zr-(ST) production was performed with an 89Y foil on a TR 19 cyclotron at 13.8 MeV. For LT production; an aqueous solution of yttrium nitrate (Y(NO3)3 · 6H2O) was irradiated on a TR 13 cyclotron at 12 MeV. 89Zr was purified from the ST or LT material with hydroxamate resin, and used to radiolabel p-SCN-Bn-Deferoxamine (DFO)-conjugated Trastuzumab. MicroPET-CT imaging was performed at 1, 3 and 5 days post-injection of 89Zr-DFO-Trastuzumab from ST or LT with biodistribution analysis on day 5.
Results …
引用总数
201820192020202120222023333123
学术搜索中的文章